Caricamento...
Rivastigmine for Alzheimer's disease
BACKGROUND: Alzheimer's disease is the commonest cause of dementia affecting older people. One of the therapeutic strategies aimed at ameliorating the clinical manifestations of Alzheimer's disease is to enhance cholinergic neurotransmission in the brain by the use of cholinesterase inhibi...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2015
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7050299/ https://ncbi.nlm.nih.gov/pubmed/26393402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001191.pub4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|